Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹76.25.
30 Oct: open ₹77.77, high ₹77.77, low ₹76.60
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹277 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.89
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 6,475
Lyka Labs share news and announcements
1,492 announcements, routine notices left out, newest first. Page 9 of 30.
Jan 2023
18 Jan · Board meeting
Dec 2022
Nov 2022
29 Nov · Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015
23 Nov · Related Party Transaction
23 Nov · Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
9 Nov · Board meeting
Oct 2022
12 Oct · No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Statement Of Investor Complaints For The Quarter Ended September 2022
Sep 2022
5 Sep · Meeting
Aug 2022
29 Aug · Legal
Clarification sought from Lyka Labs Ltd26 Aug · Legal
The exchange asked on 26 Aug 2022
25 Aug · Legal
The exchange asked on 24 Aug 2022
18 Aug · Meeting
11 Aug · Legal
Exchange has sought clarification from Lyka Labs Limited with respect to announcement dated 09-Aug-2022 informing about Appointment of Director.On the basis of aforesaid announcement, the Company is required to provide/clarify the following: 1. Disclosure of relationships between directors (in case of appointment of a directors) 2. Brief profile (in case of appointment) 3. Confirmation from Director that there are no material reasons for resignation other than that disclosed 4. Affirmation that the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority The response of the company is awaited.9 Aug · Intimation Of Reconstitution Of Audit Committee, Nomination & Remuneration Committee, Stakeholders Relationship Committee, Risk Management Committee And Corporate Social Responsibility (CSR) Committee Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015